Verastem’s treatment of low grade serous ovarian cancer, or LGSOC, was granted orphan designation by the FDA, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VSTM: